BrainWise | Brain Science for Healthy Living(@BrainWiseMedia) 's Twitter Profile Photo

Get ready to be inspired by Dr. Roebuck Spencer, a true warrior in the face of glioblastoma

In this exclusive interview, she shares her personal journey from esteemed neuropsychologist to GBM patient.

Read now!
brainwisemedia.com/from-expert-toโ€ฆ multiforme

Get ready to be inspired by Dr. Roebuck Spencer, a true warrior in the face of glioblastoma

In this exclusive interview, she shares her personal journey from esteemed neuropsychologist to GBM patient. 

Read now!
brainwisemedia.com/from-expert-toโ€ฆ #glioblastoma #glioblastomamultiforme #GBM
account_circle
CNS Pharma(@cns_pharma) 's Twitter Profile Photo

Grab your lunch and join us today at 12 PM ET for the Virtual Investor Lunch Break: The CNSP Opportunity! Register here: bit.ly/44efENZ

$CNSP

Grab your lunch and join us today at 12 PM ET for the Virtual Investor Lunch Break: The CNSP Opportunity! Register here: bit.ly/44efENZ 

$CNSP #GlioblastomaMultiforme #GBM #Oncology
account_circle
Virtual Investor Co.(@InvestorVirtual) 's Twitter Profile Photo

Grab your lunch and get ready for our Virtual Investor Lunch Break: The CNSP Opportunity happening today at 12 PM ET! Register here: bit.ly/44efENZ

@CNS_Pharma $CNSP

Grab your lunch and get ready for our Virtual Investor Lunch Break: The CNSP Opportunity happening today at 12 PM ET! Register here: bit.ly/44efENZ   

@CNS_Pharma $CNSP #GlioblastomaMultiforme #GBM #Oncology
account_circle
Virtual Investor Co.(@InvestorVirtual) 's Twitter Profile Photo

- : John Climaco, CEO & Dr. Sandra Silberman, CMO of CNS Pharma, highlight the Companyโ€™s successful Interim Analysis results in the potentially Pivotal Study of Berubicin.

vimeo.com/896863020/647eโ€ฆ
$CNSP

account_circle
Virtual Investor Co.(@InvestorVirtual) 's Twitter Profile Photo

: John Climaco, CEO of CNS Pharma will be participating in our Virtual Investor Lunch Break: The CNSP Opportunity tomorrow at 12 PM ET. Register here: bit.ly/44efENZ

@CNS_Pharma $CNSP

#HappeningTomorrow: John Climaco, CEO of CNS Pharma will be participating in our Virtual Investor Lunch Break: The CNSP Opportunity tomorrow at 12 PM ET. Register here: bit.ly/44efENZ   

@CNS_Pharma $CNSP #GlioblastomaMultiforme #GBM #Oncology
account_circle